THP regimen achieves high response rates in HER2 positive breast cancer patients

[News]

Patients with Stage II and III (early-stage) HER2+ breast cancer usually undergo pre-operative therapy with multi-agent chemotherapy in combination with anti-HER2 antibodies, followed by surgery.

More... (https://www.news-medical.net/news/20250602/THP-regimen-achieves-high-response-rates-in-HER2-positive-breast-cancer-patients.aspx)